360 related articles for article (PubMed ID: 19058970)
1. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
4. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
[TBL] [Abstract][Full Text] [Related]
6. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
[TBL] [Abstract][Full Text] [Related]
7. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.
Vicente E; Lima LM; Bongard E; Charnaud S; Villar R; Solano B; Burguete A; Perez-Silanes S; Aldana I; Vivas L; Monge A
Eur J Med Chem; 2008 Sep; 43(9):1903-10. PubMed ID: 18215443
[TBL] [Abstract][Full Text] [Related]
9. A macrolactone from benzo[a]phenazine with potent activity against Mycobacterium tuberculosis.
Silva RS; Pinto Mdo C; Goulart MO; de Souza Filho JD; Neves I; Lourenço MC; Pinto AV
Eur J Med Chem; 2009 May; 44(5):2334-7. PubMed ID: 18662840
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
[TBL] [Abstract][Full Text] [Related]
12. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
17. Antitubercular agents. Part 2: new thiolactomycin analogues active against Mycobacterium tuberculosis.
Kamal A; Shaik AA; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1927-9. PubMed ID: 15780635
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Asadipour A
Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activity of 1-substituted indolizines.
Gundersen LL; Negussie AH; Rise F; ØStby OB
Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
Foroumadi A; Soltani F; Mirzaei M
Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]